Cabozantinib,Nivolumab,Ipilimumab
Exelixis,bms
['kidney cancer', 'beat ', 'cabozantinib', 'exelixis']
cabozantinib regimen beat the doublet in pfs in untreated advanced kidney cancer. we spoke with of about the findings and their potential implications. #mededucation #meded #medtwitter #oncoalert #esmo22 
The content you need, when you need it.